You are here

Mechanisms of PSK Enhancement of Docetaxel in a Xenograft of Human Prostate Cancer

Study area

Principal investigator

Cynthia Wenner, PhD
Project period
2008 – 2011

The objective of this study is to better understand the mechanisms of polysaccharide krestin, an extract of mushroom Trametes versicolor, enhancement of docetaxel for the treatment of hormone refractory prostate cancer (HRPC) to lay the groundwork for a Phase I dose escalation trial in patients with HRPC.